Navigation Links
Professor Steven V. Ley Speaks at WuXi PharmaTech
Date:10/7/2010

Professor Steven V. Ley Speaks at WuXi PharmaTech -- SHANGHAI, Oct. 7 /PRNewswire-Asia/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Pharmaceuticals Click to view news release full screen  

Professor Steven V. Ley Speaks at WuXi PharmaTech

 
Download image

SHANGHAI, Oct. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that Dr. Steven V. Ley, BP Professor of Chemistry at the University of Cambridge, visited WuXi AppTec facilities in Shanghai on September 28. He gave a lecture to WuXi scientists titled "New Tools for Synthesis: Enabling Technologies" as part of the WuXi AppTec Science Seminar Series.

(Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO)

Dr. Ley is a world-renowned organic chemist. He founded the Ley Group, which has published extensively on the synthesis of natural products and has synthesized more than 130 target compounds. Dr. Ley's work on iron chemistry, encapsulated reagents, microbial oxidation, spiroketals, and microwave chemistry has been groundbreaking. He has pioneered the use of immobilized reagents in multi-step organic synthesis to make compounds in a cleaner and more effective way. This work now incorporates flow chemistry for multistep organic synthesis applications. He has devised many practical and useful protecting groups using acetal chemistry. He has done significant work in the area of organic catalysis and was one of the inventors of tetrapropylammonium perruthenate (TPAP), a catalytic oxidant that is now used worldwide and cited extensively.

Dr. Ley has published 698 papers to date. His recent awards include the Paracelsus Prize, the Heinrich Wieland Prize, the Tetrahedron Prize, the Perkin Prize for Organic Chemistry, the High Throughput Drug Discovery Methodologies Award, the Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery and the Hans Heroff Inhoffen Medal. In 1990 he was elected to the Royal Society (London) and was President of The Royal Society of Chemistry from 2000-2002. He was named a Commander of the Order of the British Empire (CBE) in January 2002.

"It is an honor to speak at WuXi PharmaTech, which provides high-quality research and development services to the world's leading life science companies," Dr. Ley said. "I was very impressed by WuXi's comprehensive training system and the research capabilities of WuXi scientists."

"We are privileged to have Dr. Ley share his expertise with our scientists," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec. "As we broaden our R&D service scope, our success depends on the quality of our scientists. Investing in people will continue to be our key strategy."

For more information, please contact: Stephanie Liu (for the media) Tel: +86-21-5046-4362 Email: Stephanie_liu@wuxiapptec.com Ronald Aldridge (for investors) Tel: +1-201-585-2048 Email: Ron_Aldridge@wuxiapptec.com
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award
2. NYU-Poly Professor Among First Winners of BioAccelerate NYC Prize; Project May Move Diagnostic Medicine from the Lab to the Palm of a Hand
3. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
4. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
5. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
6. WellSpring Pharmaceutical, American Gastroenterological Association, and Steven Bramson of Humanscale Partner With MediaPlanet to Publish One of the Largest Digestive Wellness Campaigns in U.S. History to Overcome Upset Stomach, Nausea, IBS, and Deb
7. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
8. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
9. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
10. D-M-S Holdings, Inc. Announces the Filing of a Lawsuit Against Veridian Healthcare, LLC, Steven M. Bisulca and Michael Mazza
11. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):